Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q9UBX8

Entry ID Method Resolution Chain Position Source
AF-Q9UBX8-F1 Predicted AlphaFoldDB

258 variants for Q9UBX8

Variant ID(s) Position Change Description Diseaes Association Provenance
rs763409374
CA8928865
2 S>P No ClinGen
ExAC
gnomAD
CA8928864
rs143211727
4 L>F Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
rs1251410870
CA402246823
5 R>S No ClinGen
TOPMed
gnomAD
CA8928863
rs764748373
5 R>W No ClinGen
ExAC
gnomAD
CA402246756
rs1203268610
9 R>G No ClinGen
gnomAD
rs758974344
CA8928862
9 R>L No ClinGen
ExAC
rs1598940366
CA402246727
10 V>G No ClinGen
Ensembl
CA8928861
rs776343053
10 V>I Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs371323148
CA8928860
12 N>S No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
TCGA novel 12 N>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA8928859
rs538228628
15 L>F No ClinGen
1000Genomes
ExAC
gnomAD
rs889120917
CA298289167
16 L>F No ClinGen
TOPMed
rs976297974
CA298289166
18 F>C No ClinGen
TOPMed
gnomAD
CA8928858
rs773183141
19 I>F Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
CA402246539
rs1413191387
19 I>M Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs773183141
CA402246555
19 I>V No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 19 I>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA8928857
rs139096016
20 F>I No ClinGen
ESP
ExAC
TOPMed
gnomAD
TCGA novel 23 S>A Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs748057535
CA8928856
23 S>F No ClinGen
ExAC
TOPMed
CA402246450
rs1173233546
23 S>T No ClinGen
TOPMed
rs748057535
CA402246444
23 S>Y No ClinGen
ExAC
TOPMed
rs943158474
CA298289163
24 L>F No ClinGen
TOPMed
rs1278070224
CA402246418
25 S>F No ClinGen
gnomAD
TCGA novel 25 S>P Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA8928853
rs756210082
26 S>T No ClinGen
ExAC
gnomAD
rs758575753
CA8928851
27 S>C No ClinGen
ExAC
TOPMed
gnomAD
rs758575753
CA298289162
27 S>Y No ClinGen
ExAC
TOPMed
gnomAD
rs577554431
CA8928850
28 C>G No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs577554431
CA402246385
28 C>S No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs778061781
CA8928848
30 Y>C Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
TCGA novel 30 Y>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA402246326
rs1214277270
32 I>T No ClinGen
gnomAD
rs35210437
RCV000966257
CA8928847
32 I>V No ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs1333818169
CA402246317
33 Y>C No ClinGen
gnomAD
CA402246308
rs1352834181
34 V>L No ClinGen
TOPMed
gnomAD
CA402246289
rs1318948558
36 P>S No ClinGen
gnomAD
rs1287873236
CA402155951
44 F>L No ClinGen
TOPMed
gnomAD
rs146312568
CA8928819
45 M>V No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs750092987
CA8928817
48 A>P No ClinGen
ExAC
gnomAD
TCGA novel 49 R>G Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs761646121
CA8928816
49 R>Q No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 54 R>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA8928815
COSM218553
rs761643392
60 I>V pancreas [Cosmic] No ClinGen
cosmic curated
ExAC
TOPMed
gnomAD
CA402155827
rs1195242041
62 H>Y No ClinGen
gnomAD
CA402155818
rs1260806952
63 M>K No ClinGen
gnomAD
rs768527976
COSM1740426
CA8928813
64 I>F NS [Cosmic] No ClinGen
cosmic curated
ExAC
gnomAD
rs762749156
CA8928812
66 L>R No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 68 T>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA8928811
rs775418505
69 N>D No ClinGen
ExAC
gnomAD
TCGA novel 70 K>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1347265609
CA402155762
71 N>S No ClinGen
gnomAD
rs530028563
CA8928810
72 S>R No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs1230287385
CA402155749
73 T>A No ClinGen
gnomAD
rs1327576786
CA402155746
73 T>M No ClinGen
gnomAD
rs372526381
CA8928809
74 L>F No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA8928808
rs777959142
75 N>H No ClinGen
ExAC
gnomAD
rs955349596
CA297739615
75 N>K No ClinGen
TOPMed
gnomAD
rs115188761
CA8928807
76 G>S No ClinGen
1000Genomes
ExAC
gnomAD
CA402155386
rs1405418865
78 D>E No ClinGen
TOPMed
rs921680655
CA297732512
80 P>R No ClinGen
TOPMed
CA402155374
COSM1711171
rs1327609253
80 P>S skin [Cosmic] No ClinGen
cosmic curated
TOPMed
rs756803714
CA8928762
81 E>K No ClinGen
ExAC
TOPMed
gnomAD
CA8928761
rs541497223
81 E>V No ClinGen
1000Genomes
ExAC
gnomAD
CA8928760
rs763875463
83 N>S No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 85 S>A Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA8928759
rs758178797
87 D>N No ClinGen
ExAC
TOPMed
gnomAD
rs1290292264
CA402155304
90 V>G No ClinGen
TOPMed
rs765129509
CA402155299
91 Q>P No ClinGen
ExAC
gnomAD
rs765129509
CA8928757
91 Q>R No ClinGen
ExAC
gnomAD
rs983757056
CA297732439
94 T>A No ClinGen
TOPMed
gnomAD
COSM1740442
CA8928756
rs574354534
94 T>M haematopoietic_and_lymphoid_tissue [Cosmic] No ClinGen
cosmic curated
1000Genomes
ExAC
TOPMed
gnomAD
CA297732431
rs903338182
96 L>F No ClinGen
Ensembl
rs150412311
CA8928754
97 P>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA402155263
rs150412311
97 P>R No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs774420565
CA8928752
98 E>G No ClinGen
ExAC
gnomAD
CA8928751
rs769044404
99 N>D No ClinGen
ExAC
gnomAD
CA402155230
rs1160517830
102 Y>C No ClinGen
gnomAD
CA402155200
rs770303733
107 P>A No ClinGen
ExAC
TOPMed
gnomAD
rs770303733
CA8928748
107 P>S No ClinGen
ExAC
TOPMed
gnomAD
CA8928749
rs770303733
107 P>T No ClinGen
ExAC
TOPMed
gnomAD
CA402155194
rs1363321757
108 C>G No ClinGen
gnomAD
rs1567973612
CA402155164
112 L>Q No ClinGen
Ensembl
rs746319501
CA8928747
113 P>L No ClinGen
ExAC
gnomAD
CA8928746
rs781724599
114 Y>C No ClinGen
ExAC
gnomAD
CA297732332
rs914225321
116 R>* No ClinGen
gnomAD
TCGA novel 118 F>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1207553598
CA402153436
119 L>F No ClinGen
TOPMed
rs1207553598
CA402153441
119 L>I No ClinGen
TOPMed
rs760012180
CA8928725
120 N>S No ClinGen
ExAC
TOPMed
gnomAD
rs776990971
CA8928724
122 N>S No ClinGen
ExAC
gnomAD
CA8928723
rs771517633
123 V>E No ClinGen
ExAC
TOPMed
gnomAD
rs1347974471
CA402153355
124 S>G No ClinGen
gnomAD
CA402153348
rs1279471360
124 S>N No ClinGen
gnomAD
CA402153323
rs1270519323
125 E>D No ClinGen
gnomAD
rs373090639
CA8928721
COSM1184347
125 E>K large_intestine [Cosmic] No ClinGen
cosmic curated
ESP
ExAC
TOPMed
gnomAD
rs1429850006
CA402153318
126 V>I No ClinGen
gnomAD
rs1340108511
CA402153303
127 S>G No ClinGen
gnomAD
rs771596136
CA8928720
129 D>E No ClinGen
ExAC
gnomAD
rs747742960
CA8928719
130 E>D No ClinGen
ExAC
gnomAD
CA402153202
rs1445185396
132 H>L No ClinGen
TOPMed
rs778544529
CA297723521
133 Q>H No ClinGen
ExAC
TOPMed
gnomAD
CA402153183
rs1567966300
133 Q>R No ClinGen
Ensembl
CA8928715
rs779821972
136 S>C No ClinGen
ExAC
TOPMed
gnomAD
CA402153113
rs779821972
136 S>F Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs199941208
COSM1388384
CA8928713
140 D>N large_intestine [Cosmic] No ClinGen
cosmic curated
ESP
ExAC
TOPMed
gnomAD
rs1260503612
CA402153011
140 D>V No ClinGen
gnomAD
CA402152994
rs1189664785
141 I>T No ClinGen
gnomAD
CA297723492
rs1056309124
143 P>A No ClinGen
TOPMed
rs764209448
CA8928712
143 P>L No ClinGen
ExAC
gnomAD
CA402152929
rs1278962933
145 G>D No ClinGen
gnomAD
CA402152931
rs1278962933
145 G>V No ClinGen
gnomAD
TCGA novel 145 G>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs763129897
CA8928711
146 H>R No ClinGen
ExAC
TOPMed
TCGA novel 146 H>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs939192644
CA297723491
147 W>C No ClinGen
TOPMed
rs1207460785
CA402152885
148 R>K No ClinGen
gnomAD
rs926517033
CA297723484
148 R>W No ClinGen
TOPMed
TCGA novel 151 D>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA8928708
rs369396189
154 P>T No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1231136438
CA402152771
155 R>G No ClinGen
TOPMed
CA8928707
rs145403140
157 K>N No ClinGen
ESP
ExAC
gnomAD
CA402151167
rs1335707402
158 V>A No ClinGen
gnomAD
CA402151161
rs1312294233
159 A>S No ClinGen
gnomAD
rs1187933337
CA402151108
162 I>V No ClinGen
TOPMed
CA8928695
rs371621631
165 R>C Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
CA297720155
rs1056400957
166 N>S No ClinGen
TOPMed
gnomAD
CA8928694
rs180688911
167 R>C No ClinGen
1000Genomes
ExAC
gnomAD
CA402151030
rs180688911
167 R>G No ClinGen
1000Genomes
ExAC
gnomAD
CA402151023
COSM1388382
rs1328338345
167 R>H large_intestine [Cosmic] No ClinGen
cosmic curated
gnomAD
rs1328338345
CA402151021
167 R>P No ClinGen
gnomAD
CA8928693
rs115568058
168 H>Y No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs368163743
CA8928692
173 I>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
TCGA novel 175 F>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 175 F>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1408107538
CA402150916
177 H>R No ClinGen
gnomAD
rs929225470
CA297720150
177 H>Y No ClinGen
TOPMed
CA8928690
rs199540062
179 I>V No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
TCGA novel 180 P>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA8928689
rs765525965
181 M>V No ClinGen
ExAC
TOPMed
gnomAD
rs1214023755
CA402150838
184 K>T No ClinGen
gnomAD
CA8928687
rs754031469
185 Q>H No ClinGen
ExAC
gnomAD
rs915348123
CA297720141
186 R>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
COSM1303676
rs1265039087
CA402150806
186 R>W urinary_tract [Cosmic] No ClinGen
cosmic curated
gnomAD
CA8928686
rs766710771
188 E>G No ClinGen
ExAC
gnomAD
rs1239597550
CA402150767
189 F>L No ClinGen
gnomAD
CA402150733
rs760954653
190 A>G No ClinGen
ExAC
TOPMed
gnomAD
CA8928685
rs760954653
190 A>V No ClinGen
ExAC
TOPMed
gnomAD
CA402150670
rs1216027815
194 I>V No ClinGen
TOPMed
CA8928652
rs759374765
200 Q>H No ClinGen
ExAC
gnomAD
rs1344921849
CA402149129
202 F>C No ClinGen
gnomAD
CA402149103
rs1484637669
204 R>C Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
rs776527478
CA8928651
205 A>T No ClinGen
ExAC
gnomAD
CA297716611
rs901456078
205 A>V Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
CA402149049
rs895863823
208 F>C No ClinGen
TOPMed
rs895863823
CA297716608
208 F>S No ClinGen
TOPMed
CA402149033
rs746887661
209 N>K No ClinGen
ExAC
TOPMed
gnomAD
rs1422355352
CA402149038
209 N>S No ClinGen
TOPMed
CA297716605
rs1040036030
211 G>V No ClinGen
TOPMed
rs1567958577
CA402149005
212 F>C No ClinGen
Ensembl
rs1393426662
CA402148997
213 K>Q No ClinGen
TOPMed
rs768779660
CA8928647
215 A>S No ClinGen
ExAC
gnomAD
CA297716560
CA297716564
rs190821754
216 M>I Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
1000Genomes
TOPMed
NCI-TCGA
COSM184408
CA8928646
rs749390292
216 M>V large_intestine Variant assessed as Somatic; impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
ExAC
NCI-TCGA
gnomAD
CA402148924
rs1312951113
218 D>G No ClinGen
gnomAD
rs879108763
CA297716555
219 S>G No ClinGen
Ensembl
CA402148885
rs1395003682
221 W>L No ClinGen
gnomAD
CA402148869
rs1399904040
222 D>G No ClinGen
gnomAD
rs1170155367
CA402148818
225 I>V No ClinGen
TOPMed
gnomAD
CA297716545
rs771234493
226 F>L No ClinGen
TOPMed
CA8928642
rs781475875
235 N>S No ClinGen
ExAC
gnomAD
CA8928640
rs181651811
236 D>V No ClinGen
1000Genomes
ExAC
gnomAD
CA8928641
rs757620997
236 D>Y No ClinGen
ExAC
gnomAD
rs762503282
CA8928638
237 R>Q No ClinGen
ExAC
TOPMed
gnomAD
CA402148552
rs1441935349
237 R>W No ClinGen
TOPMed
gnomAD
rs370233035
CA297716501
241 G>E No ClinGen
ESP
rs759217309
CA8928634
241 G>R No ClinGen
ExAC
gnomAD
rs776439295
CA8928633
245 M>L No ClinGen
ExAC
gnomAD
CA8928632
rs770786176
245 M>T No ClinGen
ExAC
gnomAD
rs370684224
CA297716484
247 R>C No ClinGen
ESP
TCGA novel 247 R>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs961906336
CA297716483
248 H>N No ClinGen
TOPMed
CA8928631
rs760617720
251 A>T No ClinGen
ExAC
gnomAD
rs943045028
CA297716482
252 K>Q No ClinGen
Ensembl
rs1247635597
CA402146899
262 Y>C No ClinGen
gnomAD
CA8928606
rs769858727
263 K>E No ClinGen
ExAC
gnomAD
TCGA novel 266 F>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 267 G>W Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1283752577
CA402146809
274 V>M No ClinGen
gnomAD
rs1242772806
CA402146795
275 E>K No ClinGen
TOPMed
gnomAD
CA402146705
rs1236373865
279 K>R No ClinGen
gnomAD
rs1567956135
CA402146695
280 I>V No ClinGen
Ensembl
CA8928602
rs747287363
281 N>S No ClinGen
ExAC
gnomAD
CA8928601
rs549667383
285 N>K No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs1378056260
CA402146557
286 A>T No ClinGen
gnomAD
rs1277424159
CA402146511
288 W>R No ClinGen
TOPMed
rs1329499982
CA402146458
289 G>* No ClinGen
gnomAD
rs1300283261
CA402146450
COSM563513
289 G>V lung Variant assessed as Somatic; 0.0 impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
NCI-TCGA
gnomAD
rs1360005984
TCGA novel
CA402146394
290 W>C Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
gnomAD
NCI-TCGA
rs1156983701 292 G>missing Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No NCI-TCGA
CA8928598
rs779634049
294 D>G No ClinGen
ExAC
gnomAD
CA402146047
rs1172347863
300 R>T No ClinGen
gnomAD
rs1008300649
CA297713265
301 V>I No ClinGen
Ensembl
CA297713263
rs748607204
303 Y>C No ClinGen
ExAC
gnomAD
rs748607204
CA8928582
303 Y>S No ClinGen
ExAC
gnomAD
CA402145766
rs1171875547
304 A>G No ClinGen
TOPMed
gnomAD
CA297713262
rs1035864200
304 A>T No ClinGen
TOPMed
gnomAD
rs779544173
CA8928581
305 G>R No ClinGen
ExAC
gnomAD
rs755585691
CA8928580
308 V>I No ClinGen
ExAC
TOPMed
gnomAD
CA402145502
rs1180198163
312 E>A No ClinGen
TOPMed
TCGA novel 313 G>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA8928578
rs779649111
313 G>R No ClinGen
ExAC
gnomAD
CA8928577
rs755650938
314 D>G No ClinGen
ExAC
TOPMed
gnomAD
CA402145335
rs1217856730
318 Y>* No ClinGen
gnomAD
CA402145305
rs1412287066
319 K>N No ClinGen
TOPMed
rs1055514077
CA297713240
322 P>L No ClinGen
Ensembl
TCGA novel 322 P>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 323 H>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1230037848
CA402145064
326 R>G No ClinGen
gnomAD
CA8928572
rs763907690
330 Q>L No ClinGen
ExAC
gnomAD
CA402144937
rs763907690
330 Q>P No ClinGen
ExAC
gnomAD
rs1332441165
CA402144815
334 R>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs1403166626
CA402144821
334 R>W No ClinGen
TOPMed
gnomAD
CA402144062
rs1464770128
336 K>T No ClinGen
TOPMed
TCGA novel 341 S>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA402143980
rs1437541912
342 K>R No ClinGen
gnomAD
CA8928556
rs756893651
343 E>D No ClinGen
ExAC
TOPMed
gnomAD
CA8928555
rs751234543
344 R>C Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA8928554
rs777486671
344 R>H No ClinGen
ExAC
TOPMed
gnomAD
CA402143949
rs777486671
344 R>P No ClinGen
ExAC
TOPMed
gnomAD
CA402143913
rs1265095013
347 I>L No ClinGen
gnomAD
CA402143901
rs375001901
347 I>M No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs1265095013
CA402143910
347 I>V No ClinGen
gnomAD
rs752627627
CA8928552
348 D>N No ClinGen
ExAC
gnomAD
CA8928551
rs765279637
350 L>V No ClinGen
ExAC
gnomAD
CA8928549
rs750560235
351 N>K No ClinGen
ExAC
TOPMed
gnomAD
CA8928550
rs760651288
351 N>S No ClinGen
ExAC
gnomAD
CA8928548
rs767528764
353 L>V No ClinGen
ExAC
gnomAD
CA8928547
rs116094076
354 I>M No ClinGen
1000Genomes
ExAC
gnomAD
rs1598858762
CA402143752
358 K>R No ClinGen
Ensembl
rs76837639
CA297712635
359 I>L No ClinGen
Ensembl
TCGA novel 359 I>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA402143682
rs1291436692
363 R>G No ClinGen
TOPMed
gnomAD
rs1156671433
CA402143674
363 R>M No ClinGen
TOPMed
gnomAD
rs763481426
CA8928544
366 T>A No ClinGen
ExAC
gnomAD
CA297712627
rs371220404
368 I>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA8928543
rs371220404
368 I>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
TCGA novel 369 S>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs770383246
CA8928542
373 M>V No ClinGen
ExAC
CA402143531
rs1370280282
374 P>A No ClinGen
Ensembl
COSM987647
CA402143507
rs1432388219
377 A>D Variant assessed as Somatic; 0.0 impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
gnomAD
rs1176444088
CA402143509
377 A>S No ClinGen
gnomAD
CA402143511
rs1176444088
377 A>T No ClinGen
gnomAD
rs770351981
CA8928539
378 P>A No ClinGen
ExAC
gnomAD
CA8928538
rs372756128
378 P>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs34683195
CA8928537
VAR_054023
379 I>V No ClinGen
UniProt
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs758183089
CA8928536
380 E>K No ClinGen
ExAC
gnomAD
CA402143457
rs1485175937
382 Y>C No ClinGen
TOPMed
gnomAD

No associated diseases with Q9UBX8

2 regional properties for Q9UBX8

Type Name Position InterPro Accession
domain Galactosyltransferase, C-terminal 247 - 324 IPR027791
domain Galactosyltransferase, N-terminal 108 - 242 IPR027995

Functions

Description
EC Number 2.4.1.274 Hexosyltransferases
Subcellular Localization
  • Golgi apparatus, Golgi stack membrane ; Single-pass type II membrane protein
  • Trans cisternae of Golgi stack
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

4 GO annotations of cellular component

Name Definition
Golgi apparatus A membrane-bound cytoplasmic organelle of the endomembrane system that further processes the core oligosaccharides (e.g. N-glycans) added to proteins in the endoplasmic reticulum and packages them into membrane-bound vesicles. The Golgi apparatus operates at the intersection of the secretory, lysosomal, and endocytic pathways.
Golgi cisterna membrane The lipid bilayer surrounding any of the thin, flattened compartments that form the central portion of the Golgi complex.
Golgi membrane The lipid bilayer surrounding any of the compartments of the Golgi apparatus.
integral component of membrane The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.

3 GO annotations of molecular function

Name Definition
galactosyltransferase activity Catalysis of the transfer of a galactosyl group to an acceptor molecule, typically another carbohydrate or a lipid.
metal ion binding Binding to a metal ion.
UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity Catalysis of the reaction: UDP-D-galactose + a glucosylceramide = a lactosylceramide + uridine-5'-diphosphate. The glucosylceramide has sphinganine as the long chain base.

9 GO annotations of biological process

Name Definition
carbohydrate metabolic process The chemical reactions and pathways involving carbohydrates, any of a group of organic compounds based of the general formula Cx(H2O)y.
central nervous system myelination The process in which neuronal axons and dendrites become coated with a segmented lipid-rich sheath (myelin) to enable faster and more energetically efficient conduction of electrical impulses. The sheath is formed by the cell membranes of oligodendrocytes in the central nervous system. Adjacent myelin segments are separated by a non-myelinated stretch of axon called a node of Ranvier.
central nervous system neuron axonogenesis Generation of a long process from a neuron whose cell body resides in the central nervous system. The process carries efferent (outgoing) action potentials from the cell body towards target cells.
ganglioside biosynthetic process via lactosylceramide The chemical reactions and pathways resulting in the formation of gangliosides that begins with the formation of lactosylceramides, Gal-beta-(1->4)-Glc-beta-(1->1') ceramides, any compound formed by the replacement of the glycosidic C1 hydroxyl group of lactose by a ceramide group.
glycosphingolipid biosynthetic process The chemical reactions and pathways resulting in the formation of glycosphingolipid, a compound with residues of sphingoid and at least one monosaccharide.
glycosylation The covalent attachment and further modification of carbohydrate residues to a substrate molecule.
lactosylceramide biosynthetic process The chemical reactions and pathways resulting in the formation of lactosylceramides, Gal-beta-(1->4)-Glc-beta(1->1') ceramides, any compound formed by the replacement of the glycosidic C1 hydroxyl group of lactose by a ceramide group. They are the precursors of both gangliosides and globosides.
neuron maturation A developmental process, independent of morphogenetic (shape) change, that is required for a neuron to attain its fully functional state.
protein glycosylation A protein modification process that results in the addition of a carbohydrate or carbohydrate derivative unit to a protein amino acid, e.g. the addition of glycan chains to proteins.

1 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q9UBV7 B4GALT7 Beta-1,4-galactosyltransferase 7 Homo sapiens (Human) PR
10 20 30 40 50 60
MSVLRRMMRV SNRSLLAFIF FFSLSSSCLY FIYVAPGIAN TYLFMVQARG IMLRENVKTI
70 80 90 100 110 120
GHMIRLYTNK NSTLNGTDYP EGNNSSDYLV QTTTYLPENF TYSPYLPCPE KLPYMRGFLN
130 140 150 160 170 180
VNVSEVSFDE IHQLFSKDLD IEPGGHWRPK DCKPRWKVAV LIPFRNRHEH LPIFFLHLIP
190 200 210 220 230 240
MLQKQRLEFA FYVIEQTGTQ PFNRAMLFNV GFKEAMKDSV WDCVIFHDVD HLPENDRNYY
250 260 270 280 290 300
GCGEMPRHFA AKLDKYMYIL PYKEFFGGVS GLTVEQFRKI NGFPNAFWGW GGEDDDLWNR
310 320 330 340 350 360
VHYAGYNVTR PEGDLGKYKS IPHHHRGEVQ FLGRYKLLRY SKERQYIDGL NNLIYRPKIL
370 380
VDRLYTNISV NLMPELAPIE DY